<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.5-a.3'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//yuchunbiotech.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://yuchunbiotech.com/en/2026/11/16/yc-biotech-supports-yd-bio-in-advancing-u-s-regulatory-development-of-ydb-lmscev-001-fda-agrees-to-provide-written-interact-feedback/</loc>
  <lastmod>2026-11-16T08:51:42Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>昱君生技 YC Biotech</news:name>
    <news:language>zh-tw</news:language>
   </news:publication>
   <news:title>YC Biotech Supports YD Bio in Advancing U.S. Regulatory Development of YDB-LMSCEV-001; FDA Agrees to Provide Written INTERACT Feedback</news:title>
   <news:publication_date>2026-11-16T08:30:27Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://yuchunbiotech.com/2026/11/16/%e6%98%b1%e5%90%9b%e7%94%9f%e6%8a%80%e5%8d%94%e5%8a%a9%e6%b0%b8%e9%bc%8e%e9%86%ab%e8%97%a5%e6%8e%a8%e9%80%b2-ydb-lmscev-001-%e7%be%8e%e5%9c%8b%e6%b3%95%e8%a6%8f%e9%96%8b%e7%99%bc%ef%bc%8c%e7%8d%b2-fda/</loc>
  <lastmod>2026-11-16T08:27:51Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>昱君生技 YC Biotech</news:name>
    <news:language>zh-tw</news:language>
   </news:publication>
   <news:title>昱君生技協助永鼎醫藥推進 YDB-LMSCEV-001 美國法規開發，獲 FDA 同意提供書面指引</news:title>
   <news:publication_date>2026-11-16T08:19:33Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
